Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Sandy Estrada"'
Publikováno v:
Drugs - Real World Outcomes, Vol 7, Iss S1, Pp 6-12 (2020)
Abstract Background Oritavancin is a FDA-approved single-dose IV therapy for the treatment of acute bacterial skin and skin structure infections caused (or suspected to be caused) by certain Gram-positive pathogens, including methicillin-resistant St
Externí odkaz:
https://doaj.org/article/98f4e78681fa449881cd261d29dc2165
Autor:
Caroline Derrick, P. Brandon Bookstaver, Zhiqiang K. Lu, Christopher M. Bland, S. Travis King, Kayla R. Stover, Kathey Rumley, Shawn H. MacVane, Jenna Swindler, Scott Kincaid, Trisha Branan, David Cluck, Benjamin Britt, Kelly E. Pillinger, Bruce M. Jones, Virginia Fleming, V. Paul DiMondi, Sandy Estrada, Brad Crane, Brian Odle, Majdi N. Al-Hasan, Julie Ann Justo
Publikováno v:
Antibiotics, Vol 9, Iss 5, p 254 (2020)
Objectives: There is debate on whether the use of third-generation cephalosporins (3GC) increases the risk of clinical failure in bloodstream infections (BSIs) caused by chromosomally-mediated AmpC-producing Enterobacterales (CAE). This study evaluat
Externí odkaz:
https://doaj.org/article/f9f3f6fd996d4836b2e3f9a7e854a568
Autor:
Sandy Estrada, Wondwosen Demisse, Mohammadmehdi Kabirnajafi, Lei Wang, Takele Gemeda, Jiajun Xu
Publikováno v:
International Journal of Energy Research. 46:3335-3348
Publikováno v:
Drugs-Real World Outcomes, Vol 7, Iss S1, Pp 6-12 (2020)
Drugs-Real World Outcomes
Drugs-Real World Outcomes
Background Oritavancin is a FDA-approved single-dose IV therapy for the treatment of acute bacterial skin and skin structure infections caused (or suspected to be caused) by certain Gram-positive pathogens, including methicillin-resistant Staphylococ
Autor:
Miguel Sierra-Hoffman, Jill Massey, Cynthia Kennedy, Sandy Estrada, Kristie Zappas, Russell J Benefield, Mark Redell, Patricia Caruso, Kimberly Leuthner
Publikováno v:
Infectious Diseases in Clinical Practice. 28:209-215
Publikováno v:
Volume 2B: Advanced Manufacturing.
Effective system energy management and cooling is critical for a range of increasingly complex systems and missions. Various industries and agencies seek technologies to use energy more efficiently in various applications, and thereby increase system
Autor:
Jenna Swindler, Kathey Fulton Rumley, Majdi N. Al-Hasan, V. Paul DiMondi, Shawn H. MacVane, Scott Kincaid, Kayla R. Stover, Virginia Fleming, Kelly E. Pillinger, Christopher M. Bland, Trisha Branan, P. Brandon Bookstaver, Brian Odle, Caroline Derrick, Zhiqiang K. Lu, S. Travis King, Sandy Estrada, David Cluck, Julie Ann Justo, Brad Crane, Bruce M Jones, Benjamin B Britt
Publikováno v:
Antibiotics
Antibiotics, Vol 9, Iss 254, p 254 (2020)
Volume 9
Issue 5
Antibiotics, Vol 9, Iss 254, p 254 (2020)
Volume 9
Issue 5
Objectives: There is debate on whether the use of third-generation cephalosporins (3GC) increases the risk of clinical failure in bloodstream infections (BSIs) caused by chromosomally-mediated AmpC-producing Enterobacterales (CAE). This study evaluat
Autor:
Susan L. Davis, Natalie A. Finch, Molly E. Steed, Taylor Morrisette, Evan J Zasowski, Sarah M Melvin, Sarah C J Jorgensen, Trang D Trinh, Samuel Simon, Joshua R Rosenberg, Sahil Bhatia, Sandy Estrada, Abdalhamid M Lagnf, Michael J. Rybak
Publikováno v:
Antimicrob Agents Chemother
Our objective was to describe the prescribing practices, clinical characteristics, and outcomes of patients treated with ceftolozane-tazobactam (C/T) for multidrug-resistant (MDR) Gram-negative infections. This was a multicenter, retrospective, cohor
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 17, Iss 1, Pp 1-6 (2018)
Annals of Clinical Microbiology and Antimicrobials
Annals of Clinical Microbiology and Antimicrobials
Background Clostridium difficile-associated diarrhea (CDAD) is a major public health threat that results in increased length of stay, hospital readmissions, deaths, and economic burden. CDAD treatment is often guided by severity of disease. Although
Autor:
Sandy Estrada, Abdalhamid M Lagnf, Michael J. Rybak, Vanthida Huang, Sarah C J Jorgensen, Evan J Zasowski, Susan L. Davis, Keith S Kaye, D. J. Delaportes, Trang D Trinh, Kimberly C. Claeys, Kenneth P. Klinker
Publikováno v:
Antimicrobial Agents and Chemotherapy. 63
The objective of this study was to determine if real-world ceftaroline treatment in adults hospitalized for acute bacterial skin and skin structure infections (ABSSSI) is associated with decreased infection-related length of stay (LOS(inf)) compared